GEN Magazine Volume 31, Issue No. 13, July 1 2011 Website Content From This Issue Website Content from This IssueInsightsaCGH Opens Up Novel Avenues of StudyAugust 1, 2011InsightsModulation of G-Protein Coupled ReceptorsJuly 1, 2011NewsRoyalty-Free Kits for Drug Production Unveiled at “ESACT”July 1, 2011InsightsRegenerative Medicine Field Takes ShapeJuly 1, 2011InsightsAchieving Optimal Expression for FabsJuly 1, 2011InsightsStrategies for Optimizing Peptide SynthesisJuly 1, 2011InsightsCMOs Investing in Capacity & CapabilitiesJuly 1, 2011InsightsHigh-Throughput Gene-Expression ProfilingJuly 1, 2011InsightsDNA Cloning Expands into New HorizonsJuly 1, 2011InsightsFeeder-Free, Xeno-Free Culture of hESCsJuly 1, 2011InsightsDrug R&D Costs QuestionedJuly 1, 2011InsightsMultiplexing Brings HTS to Higher LevelJuly 1, 2011InsightsAmerican Peptide Expands within Its NicheJuly 1, 2011InsightsGEN’s 30th Anniversary: Factor VIII Gene Cloned by Team at Genetics InstituteJuly 1, 2011InsightsCMO Market Gets Back on the Fast TrackJuly 1, 2011InsightsMoving Quickly from an Idea to a ProductJuly 1, 2011InsightsCentral Eastern Europe Targets BiotechJuly 1, 2011InsightsHHS Puts Stamp on Personalized MedicineJuly 1, 2011InsightsAlleviating Downstream Process BottlenecksJuly 1, 2011InsightsHarnessing Nuclear ReceptorsJuly 1, 2011
